183 related articles for article (PubMed ID: 23706069)
1. The 372 T/C genetic polymorphism of TIMP-1 is associated with serum levels of TIMP-1 and survival in patients with severe sepsis.
Lorente L; Martín M; Plasencia F; Solé-Violán J; Blanquer J; Labarta L; Díaz C; Borreguero-León JM; Jiménez A; Páramo JA; Orbe J; Rodríguez JA; Salido E
Crit Care; 2013 May; 17(3):R94. PubMed ID: 23706069
[TBL] [Abstract][Full Text] [Related]
2. Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio.
Lorente L; Martín MM; Solé-Violán J; Blanquer J; Labarta L; Díaz C; Borreguero-León JM; Orbe J; Rodríguez JA; Jiménez A; Páramo JA
PLoS One; 2014; 9(4):e94318. PubMed ID: 24727739
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis.
Lorente L; Martín MM; Labarta L; Díaz C; Solé-Violán J; Blanquer J; Orbe J; Rodríguez JA; Jiménez A; Borreguero-León JM; Belmonte F; Medina JC; Llimiñana MC; Ferrer-Agüero JM; Ferreres J; Mora ML; Lubillo S; Sánchez M; Barrios Y; Sierra A; Páramo JA
Crit Care; 2009; 13(5):R158. PubMed ID: 19799791
[TBL] [Abstract][Full Text] [Related]
4. TIMP-1 gene polymorphism: are genetics able to predict outcome of septic patients?
Behnes M; Bertsch T; Hoffmann U
Crit Care; 2013 Jul; 17(4):170. PubMed ID: 23890414
[TBL] [Abstract][Full Text] [Related]
5. Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction.
Lorente L; Martín MM; Ramos L; Cáceres JJ; Solé-Violán J; Argueso M; Jiménez A; Borreguero-León JM; Orbe J; Rodríguez JA; Páramo JA
BMC Neurol; 2015 Jul; 15():111. PubMed ID: 26162891
[TBL] [Abstract][Full Text] [Related]
6. High Serum Tissue Inhibitor of Matrix Metalloproteinase-1 Levels and Mortality in Patients with Spontaneous Intracerebral Hemorrhage.
Lorente L; Martín MM; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Jiménez A
World Neurosurg; 2020 Feb; 134():e476-e480. PubMed ID: 31669537
[TBL] [Abstract][Full Text] [Related]
7. The 372 T/C genetic polymorphism of TIMP-1 as a biomarker of mortality in patients with sepsis.
Lorente L; Martín MM
Crit Care; 2013 Oct; 17(5):456. PubMed ID: 24090304
[No Abstract] [Full Text] [Related]
8. Diagnostic and prognostic value of neutrophil gelatinase-associated lipocalin, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinases-1 for sepsis in the Emergency Department: an observational study.
Wang M; Zhang Q; Zhao X; Dong G; Li C
Crit Care; 2014 Nov; 18(6):634. PubMed ID: 25407832
[TBL] [Abstract][Full Text] [Related]
9. Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury.
Lorente L; Martín MM; López P; Ramos L; Blanquer J; Cáceres JJ; Solé-Violán J; Solera J; Cabrera J; Argueso M; Ortiz R; Mora ML; Lubillo S; Jiménez A; Borreguero-León JM; González A; Orbe J; Rodríguez JA; Páramo JA
PLoS One; 2014; 9(4):e94370. PubMed ID: 24728097
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of New Diagnostic Biomarkers in Pediatric Sepsis: Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, Mid-Regional Pro-Atrial Natriuretic Peptide, and Adipocyte Fatty-Acid Binding Protein.
Alqahtani MF; Smith CM; Weiss SL; Dawson S; Ralay Ranaivo H; Wainwright MS
PLoS One; 2016; 11(4):e0153645. PubMed ID: 27089280
[TBL] [Abstract][Full Text] [Related]
11. Serum MMP-8, -9 and TIMP-1 in sepsis: high serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines.
Lauhio A; Hästbacka J; Pettilä V; Tervahartiala T; Karlsson S; Varpula T; Varpula M; Ruokonen E; Sorsa T; Kolho E
Pharmacol Res; 2011 Dec; 64(6):590-4. PubMed ID: 21742038
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase MMP-8, TIMP-1 and MMP-8/TIMP-1 ratio in plasma in methicillin-sensitive Staphylococcus aureus bacteremia.
Forsblom E; Tervahartiala T; Ruotsalainen E; Järvinen A; Sorsa T
PLoS One; 2021; 16(5):e0252046. PubMed ID: 34043679
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Value of Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis-Associated Acute Kidney Injury.
Bojic S; Kotur-Stevuljevic J; Kalezic N; Stevanovic P; Jelic-Ivanovic Z; Bilanovic D; Memon L; Damnjanovic M; Kalaba Z; Simic-Ogrizovic S
Tohoku J Exp Med; 2015 Oct; 237(2):103-9. PubMed ID: 26399271
[TBL] [Abstract][Full Text] [Related]
14. Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.
Luizon MR; Palei AC; Sandrim VC; Amaral LM; Machado JS; Lacchini R; Cavalli RC; Duarte G; Tanus-Santos JE
Pharmacogenomics J; 2014 Dec; 14(6):535-41. PubMed ID: 24913092
[TBL] [Abstract][Full Text] [Related]
15. Elevated Plasma Levels of Matrix Metalloproteinase-3 and Tissue-Inhibitor of Matrix Metalloproteinases-1 Associate With Organ Dysfunction and Mortality in Sepsis.
Jones TK; Reilly JP; Anderson BJ; Miano TA; Dunn TG; Weisman AR; Agyekum R; Feng R; Ittner CAG; Shashaty MGS; Meyer NJ
Shock; 2022 Jan; 57(1):41-47. PubMed ID: 34265829
[TBL] [Abstract][Full Text] [Related]
16. Predictive Value of Matrix Metalloproteinases and Their Inhibitors for Mortality in Septic Patients: A Cohort Study.
Serrano-Gomez S; Burgos-Angulo G; Niño-Vargas DC; Niño ME; Cárdenas ME; Chacón-Valenzuela E; McCosham DM; Peinado-Acevedo JS; Lopez MM; Cunha F; Pazin-Filho A; Ilarraza R; Schulz R; Torres-Dueñas D
J Intensive Care Med; 2020 Jan; 35(1):95-103. PubMed ID: 28931365
[TBL] [Abstract][Full Text] [Related]
17. The 4G/4G Genotype of PAI-1 Polymorphism Is Associated with Higher Plasma PAI-1 Concentrations and Mortality in Patients with Severe Sepsis.
Lorente L; Martín MM; Borreguero-León JM; Barrios Y; Solé-Violán J; Ferreres J; Labarta L; Díaz C; Jiménez A
PLoS One; 2015; 10(6):e0129565. PubMed ID: 26066833
[TBL] [Abstract][Full Text] [Related]
18. Serum MMP-8 and TIMP-1 in critically ill patients with acute respiratory failure: TIMP-1 is associated with increased 90-day mortality.
Hästbacka J; Linko R; Tervahartiala T; Varpula T; Hovilehto S; Parviainen I; Vaara ST; Sorsa T; Pettilä V
Anesth Analg; 2014 Apr; 118(4):790-8. PubMed ID: 24651234
[TBL] [Abstract][Full Text] [Related]
19. Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis after Major Abdominal Surgery.
Bojic S; Kotur-Stevuljevic J; Aleksic A; Gacic J; Memon L; Simic-Ogrizovic S
Dis Markers; 2018; 2018():5064684. PubMed ID: 29861795
[TBL] [Abstract][Full Text] [Related]
20. Associations of Matrix Metalloproteinase-9 and Tissue Inhibitory Factor-1 Polymorphisms With Parkinson Disease in Taiwan.
Chen YC; Wu YR; Mesri M; Chen CM
Medicine (Baltimore); 2016 Feb; 95(5):e2672. PubMed ID: 26844501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]